HemaSphere
(May 2023)
P04 MULTIPARAMETRIC FLOW CYTOMETRY REFINES RISK STRATIFICATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
- F. Fazio,
- G. Lapietra,
- M. Z. Limongi,
- S. Intoppa,
- M. L. Milani,
- A. Piciocchi,
- M. Martelli,
- A. Guarini,
- R. Foà,
- M. S. De Propris,
- M. T. Petrucci
Affiliations
- F. Fazio
- 1 Hematology, Department of Translational and Precision Medicine, Sapienza University, 00161 Rome, Italy
- G. Lapietra
- 1 Hematology, Department of Translational and Precision Medicine, Sapienza University, 00161 Rome, Italy
- M. Z. Limongi
- 1 Hematology, Department of Translational and Precision Medicine, Sapienza University, 00161 Rome, Italy
- S. Intoppa
- 1 Hematology, Department of Translational and Precision Medicine, Sapienza University, 00161 Rome, Italy
- M. L. Milani
- 1 Hematology, Department of Translational and Precision Medicine, Sapienza University, 00161 Rome, Italy
- A. Piciocchi
- 3 Gruppo Italiano Malattie Ematologiche dell’Adulto (GIMEMA) Data Center, Fondazione GIMEMA Franco Mandelli Onlus, Rome, Italy
- M. Martelli
- 1 Hematology, Department of Translational and Precision Medicine, Sapienza University, 00161 Rome, Italy
- A. Guarini
- 2 Department of Molecular Medicine, Sapienza University, Rome, Italy
- R. Foà
- 1 Hematology, Department of Translational and Precision Medicine, Sapienza University, 00161 Rome, Italy
- M. S. De Propris
- 1 Hematology, Department of Translational and Precision Medicine, Sapienza University, 00161 Rome, Italy
- M. T. Petrucci
- 1 Hematology, Department of Translational and Precision Medicine, Sapienza University, 00161 Rome, Italy
- DOI
-
https://doi.org/10.1097/01.HS9.0000936144.71877.38
- Journal volume & issue
-
Vol. 7,
no. S2
pp.
10
– 11
WeChat QR code